Category: Research
Five new members join the Gladstone Foundation Board
Keller's work with pluripotent stem cells has led to a platform for disease modeling and regenerative medicine
New study challenges a fundamental assumption of how proteins interact with the human genome
Shipman will build new technologies to understand the development of the brain
Gladstone scientists uncover new gatekeeper function of the anti-aging molecule
Gladstone researchers have stopped the detrimental effects of blood-brain barrier leaks
New discoveries about how cells self-organize could help researchers create more authentic organ models for research or transplantation
Gladstone researchers discover a noisy step in gene expression
Connecting the dots between human papillomavirus and smoking-related cancers
The co-inventor of CRISPR genome editing technology expands research collaborations to San Francisco's Mission Bay research community
New study from the Gladstone Institutes uncovers how the viruses bypass your body's defense mechanisms
Scientists shed light on cells' most fundamental process
Wernig was selected for his groundbreaking research in cellular reprogramming and stem cell-based therapies for genetic disease
A new computational approach from the Gladstone Institutes identifies genes that may help microbes live successfully in the human gut
Scientists at Gladstone reveal how the virus decides between fates.
Researchers at the Gladstone Institutes provide answers to decade-old questions
Transplanting a special type of neuron into the brain restores cognitive functions in Alzheimer's models, shows a new study by Gladstone scientists
Gladstone scientists identify genes that enable adult cells to divide and multiply
Gladstone launches the new Institute of Data Science and Biotechnology
Different routes of sexual transmission affect the immune system's response to a virus, shows new study.
Gladstone scientists show how a type of neuron improves procedural learning.
Scientists examine the fastest changing regions in the human genome to learn how our species evolved.
Activating a single gene is sufficient to change skin cells into stem cells.
Study will use innovative technology to focus on neurodegenerative diseases
New study explains what happens when the immune system ages
Study from the Gladstone Institutes may lead to new treatments for diseases like multiple sclerosis
Scientists develop a cheaper, quicker, and more reliable stem cell-based technology to facilitate drug discovery
The term begins on January 1, 2018
A new center at Gladstone aims to find unforeseen uses for existing drugs
An unexpected collaboration leads to the discovery of an early predictor of IBD
A single drug could attack the virus on two fronts
The discovery could improve treatments for autoimmune diseases and cancer
Studer was selected for his groundbreaking research in stem cell-based therapies for Parkinson's disease
E-Scape Bio, a Gladstone spin-off company, extends its Series A financing to generate novel therapies to treat neurodegenerative disorders
Researchers show that semen amyloids help the human body dispose of excess and defective sperm
Gladstone investigator is elected VP of the preeminent organization dedicated to stem cell research and treatments
Cells related to seizures, schizophrenia and ADHD all found in the same region of the brain
Discovery at Gladstone Institutes will help reevaluate the cause of certain cancers and developmental defects
Gladstone scientists show that a cancer drug is effective in treating common causes of heart failure
Gladstone scientists uncovered a possible strategy to "shock and kill" the virus that hides in cells
Gladstone scientists identify inflammatory pathways as a potential therapeutic target for frontotemporal dementia
Gladstone scientists are the first to produce a type of stem cell-derived neuron that could potentially help restore movement
Li Gan, PhD, a senior investigator at Gladstone, was awarded a multi-million dollar grant by the National Institute of Neurological Disorders and Stroke (NINDS) to lead a national collaboration studying how the protein tau contributes to frontotemporal dementia.
